Research to make early detection of Alzheimer’s disease more accessible

By combining a simple blood test with a cognitive exam and demographics, researchers at UNT Health Science Center were able to accurately detect Alzheimer’s disease, even in its very early stages.

The research could lead to a rapid, accurate and cost-effective way to screen for Alzheimer’s disease, said Dr. Sid O’Bryant, Interim Director of the Institute for Aging and Alzheimer’s Disease Research and one of four authors of the study in the Journal of Alzheimer’s Disease.

"We’re talking about one finger stick and a short cognitive test," Dr. O’Bryant said.  "Every patient 60 and older could get it once a year from their primary care doctor."

For the study, only two blood biomarkers were screened. The Clock Drawing Test, which requires participants to place the hands and numbers on a predetermined time, was used for the cognitive exam.

The combination of tests could make early detection more accessible to the growing population of people at risk for Alzheimer’s disease. Currently 5.2 million people have Alzheimer’s disease, but that number is expected to triple by 2050.

The prevalence of Alzheimer’s disease has led to a heightened interest in finding an accurate tool for early detection. Earlier treatment helps preserve function and leads to better outcomes, Dr. O’Bryant said.

The model could be used to screen for the disease before more expensive, time-consuming and invasive procedures are considered.

"Instead of a comprehensive dementia exam, which takes two hours, this entire process can be done in less than 10 minutes," Dr. O’Bryant said. "Then if you get a positive result, you can do a full blown blood test and brain scan."

It also would make screening available to more people.

"The problem now is there are far more elders who should be screened for cognitive loss than there is capacity," Dr. O’Bryant said. "This is cost effective, time effective, and it won’t over-burden the health care system."

The financial burden for Alzheimer’s disease is estimated at $200 billion but that could reach $1.1 trillion by 2050.

Dr. James Hall, Professor of Psychiatry and Behavioral Health also participated in the research. Melissa Edwards, a PhD student in the psychology department at UNT was lead author on the study.

Recent News

A6db708d 247f 429b 8828 578ae70ec5eb
  • Our People
|May 16, 2024

Inspirational students part of HSC’s Class of 2024

A former Fort Worth tactical medic, a first-generation college student graduating as an osteopathic physician, a labor and delivery nurse, and a couple becoming physical therapists together are just a few of the inspirational students who will walk the stage during HSC’s commencement ceremony on W...
Img 4034
  • Our People
|May 16, 2024

Association of Schools and Programs of Public Health brings inaugural community outreach event to HSC campus

On May 8, the School of Public Health at The University of North Texas Health Science Center at Fort Worth, collaborated with the Association of Schools and Programs of Public Health to bring public health advocates together both virtually and in-person. The event, titled “Framing the Future...
2780b0a9 4611 4003 B866 657551d3b26f
  • Our People
|May 15, 2024

Faculty highlight: Dr. Jehad Alzyoud

Dr. Alzyoud is an assistant professor within The University of Health Science Center at Fort Worth’s Department of Physical Therapy. He teaches the neurological rehabilitation course series. “My research is focused on understanding human balance, particularly how sitting balance impairment foll...
Karen Middle
  • Our People
|May 15, 2024

Personalized Health and Well-Being graduate pivots to altruistic career path

Karen Smith was walking around the American College of Lifestyle Medicine’s annual conference in 2022 in Orlando, Florida, when she came across The University of North Texas Health Science Center at Fort Worth’s booth. Smith, a registered dietician for almost 20 years, had already decided she wa...